BLO Cannabix Technologies Inc

Cannabix Achieves New Plateau with its FAIMS Marijuana Breathalyzer Technology

Cannabix Achieves New Plateau with its FAIMS Marijuana Breathalyzer Technology
EN
05/10/2020

Underlying

BLOCannabix Technologies Inc

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Cannabix Technologies Inc

 PRESS RELEASE
Free
BLO Cannabix Techno...

Cannabix Technologies Closes Non-Brokered Private Placement

Cannabix Technologies Closes Non-Brokered Private Placement NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES ORFOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (the “Company” or “Cannabix”) announces it has closed its previously announced non-brokered private placement financing (the "Offering") with the issuance of 1,400,000 units of the Company (the “Units”) at an issue price of CDN$0.50 per Unit for aggregate gross proceeds of CDN$700,000. Each Unit consists of one common share in the ca...

February 24, 2026 1 EN
 PRESS RELEASE
Free
BLO Cannabix Techno...

Cannabix Technologies announces Non-Brokered LIFE Private Placement

Cannabix Technologies announces Non-Brokered LIFE Private Placement   NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (the “Company or Cannabix”) is pleased to announce its intention to complete a non-brokered private placement (the "Offering") of a minimum of 1,000,000 and up to 2,000,000 units (the "Units") at a price of CDN$0.50 per Unit for gross proceeds of a minimum of CDN$500,000 and up to CDN$1,000,000. Each Unit will consist of...

February 7, 2026 1 EN
 PRESS RELEASE
Free
BLO Cannabix Techno...

Cannabix Marijuana Breath Test Featured on the Cover of AlcoPro’s 2026...

Cannabix Marijuana Breath Test Featured on the Cover of AlcoPro’s 2026 Product Catalog VANCOUVER, British Columbia, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”) a developer of marijuana and alcohol breath-testing devices, is pleased to announce that its Marijuana Breath Test (“MBT”) will be featured on the cover of the 2026 AlcoPro Inc. product catalogue (see Figure 1). AlcoPro Inc. (“AlcoPro”), based in Knoxville, TN, is a leading U.S. supplier of professional drug and alcohol testing instruments, ki...

January 22, 2026 1 EN
 PRESS RELEASE
Free
BLO Cannabix Techno...

Cannabix Secures First Distributor Order for BreathLogix Alcohol Scree...

Cannabix Secures First Distributor Order for BreathLogix Alcohol Screening Devices in Australia Cannabix has developed an autonomous alcohol breathalyzer screening device for employers and a range of industries and safety settings VANCOUVER, British Columbia, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) a developer of marijuana and alcohol breath testing devices, is pleased to announce that it has received its first product orders for BreathLogix devices and related accessories from its exclusive dist...

December 30, 2025 1 EN
 PRESS RELEASE
Free
BLO Cannabix Techno...

Cannabix Technologies Launches New Marijuana Breath Test Product Video...

Cannabix Technologies Launches New Marijuana Breath Test Product Videos as U.S. Cannabis Reclassification Underscores the Urgent Need for Innovative Public Safety Solutions VANCOUVER, British Columbia, Dec. 19, 2025 (GLOBE NEWSWIRE) --  Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) developer of marijuana and alcohol breath devices is pleased to announce that it has launched new product videos showcasing the Company’s Marijuana Breath Test (MBT) solution (Figures 1 and 2). These videos highlight the MBT’s advanced features and benefits, i...

December 19, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch